



What are they? The 14-3-3 proteins
make up a ubiquitous family that is
expressed in all eukaryotic cells.
They are small, about 28–30 kDa,
acidic and relatively abundant.
How did they get their peculiar name?
In 1968, Blake Moore and colleagues
were trying to identify proteins
unique to the brain, using starch
electrophoresis. The name refers to
both the fraction number and its
position on the gel. But it turned out
that 14-3-3 was not brain-specific. 
So what’s so interesting about them?
In 1996 14-3-3 was found to bind to a
variety of oncoproteins including
Raf-1, polyoma middle T, and
Bcr-Abl. Since then the 14-3-3
proteins have been shown to bind to
a wide variety of proteins involved in
signal transduction, cell cycle and
apoptosis. These proteins include
Cdc25, NFAT, Bad, Cbl, A20,
PI 3-kinase, IRS-1, MEKK, p130Cas,
glucocorticoid receptor and the
forkhead transcription factor.
So is there anything they don’t bind to?
The list of proteins to which they
bind grows every day. But we now
know that 14-3-3 proteins bind to a
specific serine phosphorylated
sequence. Most of the known
14-3-3-binding proteins contain
this motif.
All this binding — they must have help?
Many serine/threonine kinases are
capable of generating 14-3-3 binding
sites, including protein kinase A and
protein kinase C. Recently, attention
has focused on serine kinases
regulated by cell survival signals or
DNA damage, such as Chk1 and Akt.
So what do they do? Almost
everything. We know they are
involved in signal transduction, cell
cycle control, vesicular transport and
apoptosis. They also have something
to do with responses to growth
factors, DNA damage and
oncogenesis. For some enzymes,
14-3-3 proteins function as an
essential co-factor. For others, they
can function as an inhibitor.
How do they work? Much recent work
suggests that 14-3-3 binding is
involved in intracellular targetting.
For nuclear proteins such as Cdc25
and NFAT, 14-3-3 binding keeps
them in the cytoplasm and out of the
nucleus. For apoptotic proteins such
as BAD and A20, it keeps them away
from membranes. 14-3-3 may also
have chaperone-like functions for
some proteins.
What about this family business? In
yeast, Caenorhabditis elegans and
Drosophila, there are two 14-3-3
isoforms; in mammalian cells there
are seven. Each seems to bind to the
same serine-phosphorylated
sequence. But there are
tissue-specific differences in 14-3-3
expression and one isoform, s , is
regulated by p53 and can block the
cell cycle. Understanding the
particular function of each isoform is
one of the immediate challenges. 
Do they have commercial potential?
Drug companies have shied away
from 14-3-3 proteins because of their
ubiquitous expression and their
promiscuous binding habits. But
important roles for the protein family
in cell cycle control and apoptosis
suggest that a drug that at least
partially blocks 14-3-3 binding could
potentiate chemotherapeutic agents
that induce apoptosis. 
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Crystal structure of the 14-3-3 protein bound
to a serine-phosphorylated peptide. The
structure shows that 14-3-3 is dimeric, and
capable of binding two ligands simultaneously.
The phosphorylated serine interacts with a
cluster of basic residues near the bend in the
groove. Reproduced with permission from
Yaffe MB, et al., Cell 1997, 91:961-971.
